glp 1 nafld Dawn of an era of effective treatments for MAFLD - Gofton - 2024 - Portal Hypertension & Cirrhosis JCI Insight - Hepatocyte-derived DPP4

doi: 10.1007/BF02439268

Dosing and Titration Dosing for GLP-1 receptor agonists typically starts low and gradually increases to minimize side effects

:BIAX5567

In addition, NLRP3 knockdown also decreased PFKFB3 expression, indicating that NLRP3 inflammasome activation contributed to PFKFB3-driven glycolysis

This paper reviews clinical evidence concerning the use of carnitine supplementation in the management of VHT, VHE and acute VPA poisoning

J Neurochem 109(Suppl 1):189197 Hassel B, Sonnewald U, Fonnum F (1995) Glial-neuronal interactions as studied by cerebral metabolism of [2-13C]acetate and [1-13C]glucose: an ex vivo 13 C NMR spectroscopic study